Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Home
<
List for "J07A" (23)
–
Sort according to Concentration, Size and Price
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
Cholera, Inactivated, Whole Cell (J07AE01) 2 products
WHO-DDD
DrugBank.ca
IP
CI
V/S
Dukoral
PR
PR
k.A.
Suspension und Brausepulver zur Herstellung einer Suspension zum Einnehmen: 5 Active Agents
Bavarian Nordic Berna
GmbH
B
FB
G
IP
CI
V/S
Dukoral
2
PR
PR
k.A.
Suspension und Brausepulver zur Herstellung einer Suspension zum Einnehmen: 5 Active Agents
Bavarian Nordic Berna
GmbH
B
FB
G
Haemophilus Influenzae B, Purified Antigen Conjugated (J07AG01) 1 products
WHO-DDD
DrugBank.ca
L
IP
V/S
Hiberix
Set(s)
16.16
34.00
10 %
Haemophilus Influenzae b Polysaccharida (Prp) 10 mcg
GlaxoSmithKline AG
B / SL
FB
G
Meningococcus C, Purified Polysaccharides Antigen Conjugated (J07AH07) 1 products
WHO-DDD
DrugBank.ca
L
IP
V/S
NeisVac-C
Fertigspritze(n)
26.50
45.25
10 %
Injection suspension: Polysaccharida Neisseriae Meningitidis c (Stamm C11, De-O-Acetyliert) 10µg / 0.5ml
Pfizer AG
B / SL
FB
G
Meningococcus A,C,Y,W-135, Tetravalent Purified Polysaccharides Antigen Conjugated (J07AH08) 3 products
WHO-DDD
DrugBank.ca
L
IP
V/S
MenQuadfi
41.15
61.15
10 %
Injection solution: 4 Active Agents
Sanofi-Aventis
(Suisse) SA
B / SL
FB
G
L
IP
V/S
Menveo
Kombipackung(en)
31.69
50.90
10 %
Pulver und Lösung (Durchstechflaschen): Oligosaccharida Neisseriae Meningitidis A 10 µg
Pulver und Lösung (Durchstechflaschen): 3 Active Agents
GlaxoSmithKline AG
B / SL
FB
G
L
IP
V/S
Menveo
5 Kombipackung(en)
158.45
37.75
10 %
Pulver und Lösung (Durchstechflaschen): Oligosaccharida Neisseriae Meningitidis A 10 µg
Pulver und Lösung (Durchstechflaschen): 3 Active Agents
GlaxoSmithKline AG
B / SL
FB
G
Meningococcus B, Multicomponent Vaccine (J07AH09) 1 products
WHO-DDD
DrugBank.ca
L
IP
V/S
Bexsero
78.14
101.40
10 %
Injection suspension: 4 Active Agents
GlaxoSmithKline AG
B / SL
FB
G
Pertussis, Purified Antigen, Combinations with Toxoids (J07AJ52) 5 products
WHO-DDD
DrugBank.ca
L
IP
V/S
Boostrix
17.30
35.25
10 %
3 Active Agents
GlaxoSmithKline AG
B / SL
FB
G
IP
V/S
Boostrix
10
PR
PR
k.A.
3 Active Agents
GlaxoSmithKline AG
B
FB
G
L
IP
V/S
Adacel 0.5 ml
0.5 ml
18.70
36.75
10 %
Sanofi-Aventis
(Suisse) SA
B / SL
FB
G
IP
V/S
Adacel 0.5 ml
0.5 ml
PR
PR
k.A.
Sanofi-Aventis
(Suisse) SA
B
FB
G
IP
V/S
Adacel 0.5 ml
10 x 0.5 ml
PR
PR
k.A.
Sanofi-Aventis
(Suisse) SA
B
FB
G
Pneumococcus, Purified Polysaccharides Antigen (J07AL01) 2 products
WHO-DDD
DrugBank.ca
L
IP
V/S
Pneumovax-23
19.23
37.35
10 %
Injection solution in prefilled syringe: 19 Active Agents
MSD Merck Sharp &
Dohme AG
B / SL
FB
G
IP
V/S
Pneumovax-23
10
PR
PR
k.A.
Injection solution in prefilled syringe: 19 Active Agents
MSD Merck Sharp &
Dohme AG
B
FB
G
Pneumococcus, Purified Polysaccharides Antigen Conjugated (J07AL02) 6 products
WHO-DDD
DrugBank.ca
L
IP
V/S
Prevenar 20
59.21
80.80
10 %
Injektionssuspension in einer Fertigspritze: 14 Active Agents
Pfizer AG
B / SL
FB
G
L
IP
V/S
Prevenar 20
10
592.10
660.35
10 %
Injektionssuspension in einer Fertigspritze: 14 Active Agents
Pfizer AG
B / SL
FB
G
L
IP
V/S
Vaxneuvance
58.28
79.80
10 %
Injection suspension: 10 Active Agents
MSD Merck Sharp &
Dohme AG
B / SL
FB
G
L
IP
V/S
Vaxneuvance
10
582.80
650.25
10 %
Injection suspension: 10 Active Agents
MSD Merck Sharp &
Dohme AG
B / SL
FB
G
L
IP
V/S
Prevenar 13
Fertigspritze(n) à 0.5 ml
58.03
79.55
10 %
Injektionssuspension in einer Fertigspritze: 8 Active Agents
Pfizer AG
B / SL
FB
G
IP
V/S
Prevenar 13
10 1 Fertigspritze(n) à 0.5 ml
PR
PR
k.A.
Injektionssuspension in einer Fertigspritze: 8 Active Agents
Pfizer AG
B
FB
G
Tetanus Toxoid, Combinations with Diphtheria Toxoid (J07AM51) 1 products
WHO-DDD
DrugBank.ca
IP
Diphtherie- und Tetanus-
Adsorbatimpfstoff für
Erwachsene und Kinder ab 7
Jahren
PR
PR
k.A.
Emergent BioSolutions
Berna GmbH
FB
G
Typhoid, Oral, Live Attenuated (J07AP01) 1 products
WHO-DDD
DrugBank.ca
IP
CI
V/S
Vivotif
3
PR
PR
k.A.
Capsules: Salmonella Typhi viva Stamm ty 21a 2
Bavarian Nordic Berna
GmbH
B
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home